Follow
Kevin Skoblenick
Kevin Skoblenick
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Allosteric Modulation of the Dopamine D2 Receptor by Pro-Leu-Gly-NH2 Peptidomimetics Constrained in Either a Polyproline II Helix or a Type II β-Turn …
B Raghavan, KJ Skoblenick, S Bhagwanth, N Argintaru, RK Mishra, ...
Journal of medicinal chemistry 52 (7), 2043-2051, 2009
662009
Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia
BA Dyck, KJ Skoblenick, JM Castellano, K Ki, N Thomas, RK Mishra
Synapse 63 (8), 662-672, 2009
562009
NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades
K Skoblenick, S Everling
Journal of Neuroscience 32 (35), 12018-12027, 2012
512012
Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog
V Verma, A Mann, W Costain, G Pontoriero, JM Castellano, K Skoblenick, ...
Journal of Pharmacology and Experimental Therapeutics 315 (3), 1228-1236, 2005
492005
cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced …
S Sondhi, JM Castellano, VZ Chong, RM Rogoza, KJ Skoblenick, ...
The pharmacogenomics journal 6 (2), 131-140, 2006
472006
Ketamine-induced changes in the signal and noise of rule representation in working memory by lateral prefrontal neurons
L Ma, K Skoblenick, JK Seamans, S Everling
Journal of Neuroscience 35 (33), 11612-11622, 2015
332015
Allosteric Modulation of the Dopamine Receptor by Conformationally Constrained Type VI β-Turn Peptidomimetics of Pro-Leu-Gly-NH2
AP Vartak, K Skoblenick, N Thomas, RK Mishra, RL Johnson
Journal of medicinal chemistry 50 (26), 6725-6729, 2007
332007
Synapsin II knockout mice show sensorimotor gating and behavioural abnormalities similar to those in the phencyclidine-induced preclinical animal model of schizophrenia.
BA Dyck, KJ Skoblenick, JM Castellano, K Ki, N Thomas, RK Mishra
Schizophrenia research 97 (1-3), 292-293, 2007
332007
Ketamine alters lateral prefrontal oscillations in a rule-based working memory task
L Ma, K Skoblenick, K Johnston, S Everling
Journal of Neuroscience 38 (10), 2482-2494, 2018
322018
Dopamine-D1 and-D2 receptors differentially regulate synapsin II expression in the rat brain
VZ Chong, K Skoblenick, F Morin, Y Xu, RK Mishra
Neuroscience 138 (2), 587-599, 2006
272006
N-methyl-d-aspartate Receptor Antagonist Ketamine Impairs Action-monitoring Activity in the Prefrontal Cortex
K Skoblenick, S Everling
Journal of cognitive neuroscience 26 (3), 577-592, 2014
222014
Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor
A Mann, V Verma, D Basu, KJ Skoblenick, MGR Beyaert, A Fisher, ...
European journal of pharmacology 641 (2-3), 96-101, 2010
222010
Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment
KJ Skoblenick, JM Castellano, RM Rogoza, BA Dyck, N Thomas, ...
Apoptosis 11, 663-672, 2006
202006
Ketamine alters outcome-related local field potentials in monkey prefrontal cortex
KJ Skoblenick, T Womelsdorf, S Everling
Cerebral cortex 26 (6), 2743-2752, 2016
192016
Role of AP-2α Transcription Factor in the Regulation of Synapsin II Gene Expression by Dopamine D1 and D2 Receptors
KJ Skoblenick, N Argintaru, Y Xu, BA Dyck, D Basu, ML Tan, MF Mazurek, ...
Journal of molecular neuroscience 41, 267-277, 2010
162010
Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes
RP Daya, ML Tan, CD Sookram, K Skoblenick, RK Mishra
Brain research 1412, 28-36, 2011
142011
Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders
J Gabriele, GF Pontoriero, N Thomas, CA Thomson, K Skoblenick, ...
Cell Stress and Chaperones 14 (6), 555-567, 2009
122009
MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats
JM Castellano, J Batrynchuk, K Dolbeare, V Verma, A Mann, ...
Peptides 28 (10), 2009-2015, 2007
102007
Intravenous ketamine for depression: a clinical discussion reconsidering best practices in acute hypertension management
R Yip, J Swainson, A Khullar, RS McIntyre, K Skoblenick
Frontiers in Psychiatry 13, 1017504, 2022
52022
Mapping of human brain for glucose-dependent insulinotropic polypeptide (GIP) and GIP receptors expression: implications in schizophrenia
AN Singh, D Basu, KJ Skoblenick, JM Castellano, G Pontoriero, ...
Schizophrenia Research 2 (117), 528, 2010
32010
The system can't perform the operation now. Try again later.
Articles 1–20